Figure 2. Predicted vaccine efficacy on severe rotavirus gastroenteritis incidence in 6 to 23 month-olds.

Step-wise influence of improving the underlying natural history of protection, immunogenicity of vaccines, and baseline disease incidence. The gray shaded area on the baseline bar indicates the potential incremental increase in VE from a third dose given at 6 months of age.